Evaluating the effectiveness of conjugated pneumococcal vaccines in Colombia

被引:0
|
作者
Manjarres-Posada, N. I. [1 ]
Choconta-Piraquive, L. A. [1 ]
De la Hoz-Restrepo, F. [1 ]
机构
[1] Univ Nacl Colombia, Fac Med, Bogota, Colombia
来源
5TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS | 2012年 / 6卷
关键词
Streptococcus pneumoniae; Pneumococcal Infections; Pneumococcal Vaccines; Vaccine effectiveness; DISEASE; BURDEN;
D O I
10.1016/j.provac.2012.04.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective cohort study was conducted in 2631 Colombian children <2 yrs to evaluate pneumococcal vaccine effectiveness. Association between vaccination and disease was evaluated using Cox proportional hazards models. Vaccinated children had a significant reduction in hospitalization risk for all outcomes (HR 0,59 CI 95% 0,42 0,85) and for pneumonia the reduction was slightly higher (HR 0,53 CI 95% 0,32 - 0,89). Our results show an important risk reduction in clinical syndromes potentially associated to pneumococcus in vaccinated children confirming the benefits of using conjugate vaccines in a medium income developing country. (C) 2012 Published by Elsevier Ltd. Selection and/or peerreview under responsibility of the 5th vaccine confer organizing conunittee.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [31] Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
    Jieling Chen
    Megan A. O’Brien
    H. Keri Yang
    John D. Grabenstein
    Erik J. Dasbach
    Advances in Therapy, 2014, 31 : 392 - 409
  • [32] Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review
    Marra, Lays P.
    Sartori, Ana L.
    Martinez-Silveira, Martha S.
    Toscano, Cristiana M.
    Andrade, Ana L.
    VALUE IN HEALTH, 2022, 25 (06) : 1042 - 1056
  • [33] Letter to the editor regarding "Budget impact analysis of pneumococcal conjugate vaccines in Colombia"
    Reyes, Juan M.
    LaRotta, Jorge
    Castano, Natalia
    Fletcher, Mark A.
    Wasserman, Matthew
    Perdrizet, Johnna
    Sini de Almeida, Rodrigo
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 1 - 3
  • [34] Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
    Chen, Jieling
    O'Brien, Megan A.
    Yang, H. Keri
    Grabenstein, John D.
    Dasbach, Erik J.
    ADVANCES IN THERAPY, 2014, 31 (04) : 392 - 409
  • [35] Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines
    Weaver, M
    Krieger, J
    Castorina, J
    Walls, M
    Ciske, S
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) : 111 - 120
  • [36] Efficacy and effectiveness of pneumococcal polysaccharide vaccines and their use in industrialised countries
    Lehmann, D
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 : S41 - S44
  • [37] The potential cost-effectiveness of infant pneumococcal vaccines in Australia
    Newall, Anthony T.
    Creighton, Prudence
    Philp, David J.
    Wood, James G.
    MacIntyre, C. Raina
    VACCINE, 2011, 29 (45) : 8077 - 8085
  • [38] Effectiveness and Serotype Coverage: Key Criteria for Pneumococcal Vaccines for Adults
    Grabenstein, John D.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (02) : 255 - 258
  • [39] Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines
    Jacobs, RJ
    Meyerhoff, AS
    PREVENTIVE MEDICINE, 2001, 33 (06) : 639 - 645
  • [40] Beyond efficacy: A career evaluating the effectiveness of vaccines
    Shapiro, Eugene
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1738 - 1740